JENNIFER CARREON: Open Payments
NPI 1760030100 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$823 in 41 payments from 11 companies in 2025. Trend: 2023 $1,156 · 2024 $1,299 · 2025 $823
Food & beverage: $823
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $264 |
| GlaxoSmithKline, LLC. | 17 | $156 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Lilly USA, LLC | 5 | $86 |
| Novo Nordisk Inc | 2 | $48 |
| Verona Pharma, Inc. | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Astellas Pharma US Inc | 1 | $21 |
| Dexcom, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
Products named: BREZTRI, TRELEGY ELLIPTA, REXULTI, MOUNJARO, Rybelsus, Ohtuvayre, AIRSUPRA, Veozah.
Industry payments across TX — which companies pay providers there.
